US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 6.900
  • +0.280+4.23%
Close Dec 11 16:00 ET
  • 7.050
  • +0.150+2.17%
Post 17:08 ET
390.69MMarket Cap-8.12P/E (TTM)

Design Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
-4.57%-14.53M
-31.47%-13.8M
-47.32%-17.42M
-74.68%-51.32M
-63.55%-15.09M
Net income from continuing operations
17.42%-13.04M
40.85%-11.79M
42.44%-11.11M
-5.61%-66.86M
31.71%-11.84M
10.82%-15.79M
-32.92%-19.94M
-45.45%-19.29M
-78.17%-63.31M
-56.71%-17.34M
Depreciation and amortization
11.68%153K
13.53%151K
10.85%143K
32.27%537K
11.29%138K
26.85%137K
44.57%133K
57.32%129K
214.73%406K
51.22%124K
Other non cash items
-87.50%1K
-60.00%4K
-60.00%4K
-48.44%33K
-54.55%5K
-42.86%8K
-60.00%10K
-28.57%10K
236.84%64K
-21.43%11K
Change In working capital
519.25%1.68M
-136.75%-1.35M
-430.56%-2.93M
-63.45%728K
-3,053.97%-1.99M
-131.52%-400K
101.21%3.67M
46.67%-553K
42.69%1.99M
-139.38%-63K
-Change in prepaid assets
203.29%660K
-205.02%-628K
-134.48%-411K
158.18%1.97M
274.73%823K
66.40%-639K
175.58%598K
196.36%1.19M
-233.63%-3.39M
-334.33%-471K
-Change in payables and accrued expense
325.52%1.02M
-123.45%-720K
-44.58%-2.52M
-123.14%-1.25M
-788.73%-2.81M
-92.46%239K
91.16%3.07M
-972.50%-1.75M
123.17%5.39M
1,095.12%408K
Cash from discontinued investing activities
Operating cash flow
34.32%-9.55M
18.43%-11.26M
28.61%-12.44M
-14.11%-58.56M
15.19%-12.8M
-4.57%-14.53M
-31.47%-13.8M
-47.32%-17.42M
-74.68%-51.32M
-63.55%-15.09M
Investing cash flow
Cash flow from continuing investing activities
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
124.08%15.27M
107.63%11.98M
4,666.43%19.73M
-311.95%-220.99M
97.89%-1.06M
Net PPE purchase and sale
130.19%16K
-80.90%-161K
-124.14%-195K
72.11%-256K
90.63%-27K
82.90%-53K
63.52%-89K
-14.47%-87K
40.31%-918K
18.64%-288K
Net investment purchase and sale
-138.14%-5.84M
127.77%27.49M
5.00%20.81M
123.98%52.79M
826.82%5.58M
124.29%15.32M
107.70%12.07M
3,944.90%19.82M
-322.42%-220.11M
98.45%-768K
Net other investing changes
----
----
----
----
----
----
----
----
--39K
--0
Cash from discontinued investing activities
Investing cash flow
-138.16%-5.83M
128.12%27.33M
4.47%20.62M
123.77%52.54M
626.04%5.56M
124.08%15.27M
107.63%11.98M
4,666.43%19.73M
-311.95%-220.99M
97.89%-1.06M
Financing cash flow
Cash flow from continuing financing activities
-92.31%1K
9.05%229K
20K
208.09%724K
285.38%501K
-91.39%13K
203.96%210K
0
-99.94%235K
-32.64%130K
Proceeds from stock option exercised by employees
-92.31%1K
9.05%229K
--20K
9.37%724K
285.38%501K
-91.39%13K
-6.67%210K
--0
190.35%662K
-32.64%130K
Net other financing activities
----
----
----
----
----
----
----
----
---427K
--0
Cash from discontinued financing activities
Financing cash flow
-92.31%1K
9.05%229K
--20K
208.09%724K
285.38%501K
-91.39%13K
203.96%210K
--0
-99.94%235K
-32.64%130K
Net cash flow
Beginning cash position
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-91.12%26.5M
-34.28%27.94M
-77.27%27.2M
-89.97%28.81M
-91.12%26.5M
12,450.19%298.57M
-88.11%42.52M
Current changes in cash
-2,163.22%-15.37M
1,111.29%16.3M
255.00%8.2M
98.05%-5.3M
57.91%-6.74M
100.97%745K
99.04%-1.61M
120.51%2.31M
-191.86%-272.07M
72.90%-16.02M
End cash Position
8.54%30.33M
68.03%45.7M
2.04%29.4M
-20.00%21.2M
-20.00%21.2M
-34.28%27.94M
-77.27%27.2M
-89.97%28.81M
-91.12%26.5M
-91.12%26.5M
Free cash flow
34.67%-9.53M
17.79%-11.42M
27.85%-12.63M
-12.60%-58.82M
16.61%-12.83M
-2.66%-14.59M
-29.31%-13.89M
-47.11%-17.51M
-68.96%-52.24M
-60.52%-15.38M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M-4.57%-14.53M-31.47%-13.8M-47.32%-17.42M-74.68%-51.32M-63.55%-15.09M
Net income from continuing operations 17.42%-13.04M40.85%-11.79M42.44%-11.11M-5.61%-66.86M31.71%-11.84M10.82%-15.79M-32.92%-19.94M-45.45%-19.29M-78.17%-63.31M-56.71%-17.34M
Depreciation and amortization 11.68%153K13.53%151K10.85%143K32.27%537K11.29%138K26.85%137K44.57%133K57.32%129K214.73%406K51.22%124K
Other non cash items -87.50%1K-60.00%4K-60.00%4K-48.44%33K-54.55%5K-42.86%8K-60.00%10K-28.57%10K236.84%64K-21.43%11K
Change In working capital 519.25%1.68M-136.75%-1.35M-430.56%-2.93M-63.45%728K-3,053.97%-1.99M-131.52%-400K101.21%3.67M46.67%-553K42.69%1.99M-139.38%-63K
-Change in prepaid assets 203.29%660K-205.02%-628K-134.48%-411K158.18%1.97M274.73%823K66.40%-639K175.58%598K196.36%1.19M-233.63%-3.39M-334.33%-471K
-Change in payables and accrued expense 325.52%1.02M-123.45%-720K-44.58%-2.52M-123.14%-1.25M-788.73%-2.81M-92.46%239K91.16%3.07M-972.50%-1.75M123.17%5.39M1,095.12%408K
Cash from discontinued investing activities
Operating cash flow 34.32%-9.55M18.43%-11.26M28.61%-12.44M-14.11%-58.56M15.19%-12.8M-4.57%-14.53M-31.47%-13.8M-47.32%-17.42M-74.68%-51.32M-63.55%-15.09M
Investing cash flow
Cash flow from continuing investing activities -138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M124.08%15.27M107.63%11.98M4,666.43%19.73M-311.95%-220.99M97.89%-1.06M
Net PPE purchase and sale 130.19%16K-80.90%-161K-124.14%-195K72.11%-256K90.63%-27K82.90%-53K63.52%-89K-14.47%-87K40.31%-918K18.64%-288K
Net investment purchase and sale -138.14%-5.84M127.77%27.49M5.00%20.81M123.98%52.79M826.82%5.58M124.29%15.32M107.70%12.07M3,944.90%19.82M-322.42%-220.11M98.45%-768K
Net other investing changes ----------------------------------39K--0
Cash from discontinued investing activities
Investing cash flow -138.16%-5.83M128.12%27.33M4.47%20.62M123.77%52.54M626.04%5.56M124.08%15.27M107.63%11.98M4,666.43%19.73M-311.95%-220.99M97.89%-1.06M
Financing cash flow
Cash flow from continuing financing activities -92.31%1K9.05%229K20K208.09%724K285.38%501K-91.39%13K203.96%210K0-99.94%235K-32.64%130K
Proceeds from stock option exercised by employees -92.31%1K9.05%229K--20K9.37%724K285.38%501K-91.39%13K-6.67%210K--0190.35%662K-32.64%130K
Net other financing activities -----------------------------------427K--0
Cash from discontinued financing activities
Financing cash flow -92.31%1K9.05%229K--20K208.09%724K285.38%501K-91.39%13K203.96%210K--0-99.94%235K-32.64%130K
Net cash flow
Beginning cash position 68.03%45.7M2.04%29.4M-20.00%21.2M-91.12%26.5M-34.28%27.94M-77.27%27.2M-89.97%28.81M-91.12%26.5M12,450.19%298.57M-88.11%42.52M
Current changes in cash -2,163.22%-15.37M1,111.29%16.3M255.00%8.2M98.05%-5.3M57.91%-6.74M100.97%745K99.04%-1.61M120.51%2.31M-191.86%-272.07M72.90%-16.02M
End cash Position 8.54%30.33M68.03%45.7M2.04%29.4M-20.00%21.2M-20.00%21.2M-34.28%27.94M-77.27%27.2M-89.97%28.81M-91.12%26.5M-91.12%26.5M
Free cash flow 34.67%-9.53M17.79%-11.42M27.85%-12.63M-12.60%-58.82M16.61%-12.83M-2.66%-14.59M-29.31%-13.89M-47.11%-17.51M-68.96%-52.24M-60.52%-15.38M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data